Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Baron Select

Baron Health Care Fund Retail Shares (BHCFX)

Ticker BHCFX · Since 2018-04-30 · · Holdings as of Jun 30, 2026

Expense ratio
1.1%$110/yr per $10k
5-yr return
+2.5%annualized
1-yr return
+10.0%as of Dec 2025
Net assets
$114.1Mall share classes
Holdings
43

Bottom line

Is BHCFX a good fund? The bottom line

BHCFX is the Retail share class of Baron Health Care Fund, a managed health care sector mutual fund from Baron Select.

It charges 1.1% — about $110 a year on every $10,000 invested, more expensive than 63% of health care sector funds we track.

It returned +10.0% over one year, +2.5% a year over five years (as of Dec 31, 2025, per its prospectus).

With $114 million in net assets and 43 holdings, its largest position is Eli Lilly & Co (13.7%) and the top 10 make up 50.6% of the portfolio.

The closest lower-cost alternative we found is PRHSX (0.83%, 50% top-holdings overlap).

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 50.6% of assets
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What BHCFX invests in

The investment goal of Baron Health Care Fund (the Fund) is capital appreciation.

The Fund is a non-diversified fund that, under normal circumstances, invests at least 80% of its net assets in equity securities of companies engaged in the research, development, production, sale, delivery or distribution of products and services related to the health care industry. The Adviser uses various criteria to determine whether an issuer is engaged in activities related to the health care industry, including whether: (1) the issuer derives 50% or more of its revenues from activities in the health care industry; or (2) the issuer devotes 50% or more of its assets to producing sales from the health care industry. These companies may include, among others, pharmaceutical companies, biotechnology companies, life sciences tools and services companies, health care equipment companies, health care supplies companies, managed health care companies, health care services companies…

From the fund's prospectus (filed Apr 30, 2026).

BHCFX performance

Fund calendar-year total returns, 2019–2025 2019: +35.2%; 2020: +47.4%; 2021: +15.5%; 2022: −17.1%; 2023: +6.2%; 2024: +1.3%; 2025: +10.0% +35.2% 2019 +47.4% 2020 +15.5% 2021 −17.1% 2022 +6.2% 2023 +1.3% 2024 +10.0% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BHCFX+10.0%+2.5%—
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full BHCFX performance history →

What BHCFX costs

On a $10,000 investment, BHCFX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,340 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full BHCFX fee table →

BHCFX top 10 holdings

#Holding% of fund
1Eli Lilly & Co13.66%
2Mettler-Toledo International Inc5.60%
3Johnson & Johnson5.56%
4Argenx SE4.23%
5Thermo Fisher Scientific Inc3.91%
6Roivant Sciences Ltd3.88%
7Teva Pharmaceutical Industries Ltd3.86%
8Welltower Inc3.38%
9UnitedHealth Group Inc3.28%
10RadNet Inc3.24%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 50.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to BHCFX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
T. Rowe PricePRHSX T. Rowe Price Health Sciences Fund, Inc.0.83%50% Compare

More funds like BHCFX →

BHCFX FAQ

What is the expense ratio of BHCFX?
BHCFX's expense ratio is 1.1%, which works out to about $110 a year for every $10,000 invested. The prospectus estimates total costs of $1,340 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BHCFX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 50.6% of assets; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does BHCFX hold?
BHCFX's largest holdings are Eli Lilly & Co (13.7%), Mettler-Toledo International Inc (5.6%), Johnson & Johnson (5.6%), Argenx SE (4.2%), Thermo Fisher Scientific Inc (3.9%). It holds 43 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is BHCFX's 5-year return?
BHCFX returned +2.5% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
What is a cheaper alternative to BHCFX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) overlaps about 50% with BHCFX and charges 0.83%.
Who manages BHCFX?
BHCFX is offered by Baron Select through Baron Select Funds.